Overview A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status: Completed Trial end date: 2019-04-22 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety of INCB054707 in men and women with moderate to severe hidradenitis suppurativa (HS). Phase: Phase 2 Details Lead Sponsor: Incyte Corporation